BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced multi-functional targeted formulation features transferrin and cell-penetrating peptide co-modified liposomes. The vesicle architecture utilizes a stable phospholipid-cholesterol bilayer shell whose exterior boundary is dual-modified with macromolecular transferrin glycoproteins and specific cell-penetrating peptides (such as TAT or octa-arginine sequences) linked via covalent polymer-lipid anchors. This precise multi-ligand configuration coordinates a dense target-mimetic protein array with a highly uniform charged cell-penetrating peptide layer, altering overall membrane bending elasticity and surface charge topography to completely prevent physical vesicle aggregation while leaving the internal aqueous core completely empty.
Source
Custom synthesis
Functional Group
Transferrin; Cell-penetrating peptide (CPP)
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.